SCHEMBL11294962

SCHEMBL11294962

CC(CN(c1ccc(C(=O)NO)cc1)C1CCNC1=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 6/20 0.40
▸ HDAC8 Q9BY41 5/20 0.40
▸ HDAC1 Q13547 7/20 0.39
▸ HDAC3 O15379 2/20 0.38
▸ HDAC4 P56524 2/20 0.38
▸ HDAC7 Q8WUI4 2/20 0.38
▸ HDAC2 Q92769 2/20 0.38
▸ HDAC10 Q969S8 2/20 0.38
▸ HDAC11 Q96DB2 2/20 0.38
▸ HDAC9 Q9UKV0 2/20 0.38
▸ HDAC5 Q9UQL6 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ MCHR1 Q99705 1/20 0.36
▸ TRPM8 Q7Z2W7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301466 0.94 HDAC1 (0.44) HDAC6HDAC8HDAC1HDAC3HDAC4
SCHEMBL11300531 0.87 HDAC1 (0.42) HDAC6HDAC8HDAC1HDAC3HDAC4
SCHEMBL11301136 0.82 ROCK2 (0.42) RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL11304378 0.82 HDAC6 (0.38) HDAC6HDAC8HDAC1HDAC3HDAC4
SCHEMBL11300775 0.77 HDAC1 (0.50) HDAC6HDAC8HDAC1HDAC3HDAC4
SCHEMBL11294960 0.77 HDAC8 (0.41) HDAC6HDAC8HDAC1HDAC3HDAC4
SCHEMBL11299083 0.76 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC3HDAC2
SCHEMBL11301463 0.76 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC3HDAC4
SCHEMBL11299544 0.75 HDAC1 (0.43) HDAC6HDAC8HDAC1HDAC3HDAC4
SCHEMBL11296174 0.75 HDAC8 (0.44) HDAC6HDAC8HDAC1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback